Lifecore Biomedical, Inc.
LFCR
$7.61
$0.395.40%
NASDAQ
| 05/25/2025 | 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.81% | -194.48% | -146.22% | -50.92% | 81.97% |
| Total Depreciation and Amortization | -4.97% | 3.49% | 15.74% | -8.07% | -7.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -39.99% | 214.03% | 145.93% | 37.44% | -65.59% |
| Change in Net Operating Assets | -123.09% | 48.44% | -1,200.76% | 277.74% | -38.34% |
| Cash from Operations | -38.65% | 184.63% | -574.38% | 92.28% | 485.32% |
| Capital Expenditure | 22.71% | 14.31% | 42.03% | 32.88% | 62.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 22.71% | 124.25% | 42.03% | 32.88% | 56.01% |
| Total Debt Issued | -12.23% | -- | 13.47% | -16.09% | -17.75% |
| Total Debt Repaid | 12.34% | -2,585.78% | -5,000.89% | -796.15% | 2.78% |
| Issuance of Common Stock | -- | -- | -- | -99.86% | -- |
| Repurchase of Common Stock | -222.64% | -216.67% | -3,108.33% | -1,208.89% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -108.92% | -- | -- | 95.51% |
| Cash from Financing | 34.53% | -188.80% | 611.23% | -62.75% | -102.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.15% | -2,628.38% | 172.59% | 71.84% | -66.61% |